DUBLIN, Ohio — Mike Kaufmann has been named chief executive officer of Cardinal Health Inc., effective January 1. The 54-year-old Kaufmann, Cardinal’s chief financial officer, will succeed George Barrett. Barrett, 62, the company’s chairman and CEO since 2009, will serve as executive chairman through the annual shareholders meeting next November. Lead independent director Gregory Kenny
DUBLIN, Ohio — Building on its efforts to fight the opioid abuse epidemic, Cardinal Health Inc. has launched an initiative targeting one of the nation’s hardest-hit areas. Called the Opioid Action Program, the pilot will provide frontline tools to help thwart opioid abuse and support first responders the Appalachia region, including Ohio, Kentucky, Tennessee and West Virginia, Cardinal
DUBLIN, Ohio — Cardinal Health Inc. plans to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion. Cardinal said the agreement, announced late Tuesday, includes its pharmaceutical and medical products distribution business in China but not its other businesses there, including Cordis, the recently acquired Patient Recovery business, its
DUBLIN, Ohio — Cardinal Health Inc. has named chief financial officer Mike Kaufmann to succeed George Barrett as chief executive officer. Plans call for Kaufmann, 54, to take the CEO reins and join Cardinal’s board on Jan. 1. Barrett will continue to serve as executive chairman through the annual meeting of shareholders in November 2018, at which
DUBLIN, Ohio — Cardinal Health is prepared to play a significant role in meeting the challenge of expanding access, improving patient outcomes and lowering costs in health care, said chairman and chief executive officer George Barrett. With its integrated offerings, Cardinal Health is an essential partner for pharmacies, physicians’ offices, hospitals and other providers in
DUBLIN, Ohio — Cardinal Health Inc. is acquiring a large portion of the hospital supplies business of Medtronic PLC for $6.1 billion in cash. The purchase of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses gives Cardinal Health products in 23 categories, from catheters to tourniquet kits, and brands including Kendall, Dover, Argyle
DUBLIN, Ohio — Cardinal Health has completed its acquisition of Johnson & Johnson’s Cordis cardiology and endovascular device business for $1.944 billion. Cardinal said Sunday evening that the integration of Cordis off to a strong start, with management teams in place worldwide. The company noted that planning has been ongoing since the deal was announced
NEW YORK — Pharmaceutical distributors Cardinal Health Inc. and AmerisourceBergen Corp. this week announced the election of new board members. Cardinal said that Nancy Killefer is slated to join its board as an independent director on Sept. 14. Most recently, she was senior partner of McKinsey & Co. until her retirement in 2013. At McKinsey,
Cardinal Health chairman and CEO George Barrett was one of the performers at a Rock and Roll Hall of Fame Roadshow concert this week in Columbus, Ohio, not far from the pharmaceutical distributor’s Dublin, Ohio, headquarters. Local journal Columbus Business First reported that Barrett, a classically trained musician, played guitar, keyboards and sang at the
DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.12 billion. Based in Livonia, Mich., THDG is a distributor of generic drugs, over-the-counter medicines and related products to retail, institutional and alternate care customers. THDG had revenue of about
DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.115 billion. Cardinal said Friday that it will use cash and new debt to finance the transaction, which is expected to close in the beginning of its 2016 fiscal year,
DUBLIN, Ohio — Cardinal Health Inc. plans to acquire cardiology and endovascular device maker Cordis from Johnson & Johnson for $1.944 billion. Cardinal said Monday that the cash deal would significantly advance its offering of interventional cardiology and endovascular solutions for integrated health systems and their patients by giving the company immediate global scale in
DUBLIN, Ohio — In a settlement with the Drug Enforcement Agency (DEA), Cardinal Health Inc. has agreed to a two-year suspension of its Lakeland, Fla., distribution center’s registration to ship controlled substances. The pharmaceutical distributor said Tuesday that under the settlement it also has agreed to improve certain anti-diversion procedures. Cardinal noted that the agreement
